We are live on ! Find out more
GMOV

GMO US Value ETF

7 hedge funds and large institutions have $4.86M invested in GMO US Value ETF in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

19.88% more ownership

Funds ownership: 0%19.88% (+20%)

Holders
7
Holders Change
+7
Holders Change %
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Cerity Partners
1
Cerity Partners
New York
$2.39M +$2.47M +97,729 New
Citadel Advisors
2
Citadel Advisors
Florida
$732K +$757K +29,956 New
LCWP
3
Legacy Capital Wealth Partners
Arkansas
$491K +$507K +20,066 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$458K +$474K +18,748 New
Envestnet Asset Management
5
Envestnet Asset Management
Illinois
$420K +$435K +17,184 New
CFG
6
Certior Financial Group
Pennsylvania
$354K +$366K +14,461 New
UBS Group
7
UBS Group
Switzerland
$15K +$15.6K +615 New

GMOV Hedge Fund Activity: Q4 2024 in Review

7 of the 7,599 institutional investors tracked by Wall St. Rank reported a position in GMO US Value ETF (GMOV) for Q4 2024, worth a combined $4.86M.

Buyers outnumbered sellers: 7 funds opened new GMOV positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cerity Partners, opening a new position worth an estimated $2.47M.

  • 7 institutional investors held GMO US Value ETF (GMOV) as of Q4 2024, up from 0 in Q3 2024.
  • Funds reported $4.86M of GMO US Value ETF stock for Q4 2024.
  • 7 funds opened new GMO US Value ETF positions in Q4 2024 and 0 closed out, a net change of +7 holders.
  • The largest GMO US Value ETF buyer in Q4 2024 was Cerity Partners, an estimated $2.47M added.

Based on aggregated 13F filings for Q4 2024.